Lisata Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.15

-0.08 (-2.48%)

As of May 16, 2:22 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +912.1% upside

Low Target $19.01

Average Target $31.88

High Target $45.37

Current Price $3.15

Current
$3.15

Target
$31.88

$19.01 $31.88 avg $45.37

Scenario Analysis

Bear Case

$19.01

503.5%

Low target

Base Case

$31.88

+912.1%

Avg target

Bull Case

$45.37

+1,340.3%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$5.07

-37.9% from high

52-Week Low

$1.81

+74.0% from low

Target vs 52W High

$31.88

+528.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%